Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy

Study Identifier
GMA-OZU-10-017
CT.gov Identifier
NCT01319318
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Eye Care - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Require pars plana vitrectomy in at least 1 eye * Best corrected visual acuity in the study eye between 20/400 and 20/40
    Exclusion Criteria:
    * Use of any NSAIDs (topical or systemic) within 14 days * Use of topical or systemic steroids within 30 days * Active eye infection in either eye * Any eye surgery within 6 months * Prior pars plana vitrectomy, YAG capsulotomy or uveitis

    Protocol Summary

    This study will evaluate the degree of post-operative ocular inflammation in patients who are undergoing a pars plana vitrectomy.

    Study Locations

    Location
    Status
    Location
    San Antonio, Texas, United States
    Status
    Not applicable